Invesco’s Acutus Medical Inc AFIB Stock Holding History

Invesco’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-376,921	Closed	-$5.04M	–	4055
2021 Q1	$5.04M	Sell	376,921 -133	-0%	-$2.99K	﹤0.01%	2373
2020 Q4	$10.9M	Buy	+377,054	New	+$10.2M	﹤0.01%	1762

Other funds holding AFIB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Jetstream Capital Brentwood, Tennessee $1.37M AUM

Invesco's AFIB Position: Q2 2021 in Review

Invesco sold out of Acutus Medical Inc (AFIB) in Q2 2021, closing a stake of 376,921 shares — an estimated $5.04M sold.

Invesco first reported a position in AFIB in Q4 2020 and held it in 2 quarters. The position peaked at $10.9M in Q4 2020. 64 funds tracked by Wall St. Rank hold AFIB as of Q2 2021.

Invesco reported no remaining Acutus Medical Inc position as of Q2 2021 after selling out during the quarter.
Invesco sold 376,921 Acutus Medical Inc shares in Q2 2021, an estimated $5.04M.
Invesco first reported a position in Acutus Medical Inc in Q4 2020 and held it in 2 quarters.
Invesco's Acutus Medical Inc position peaked at $10.9M in Q4 2020.
64 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.